Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gfi1
|
ENSMUSG00000029275.11 | growth factor independent 1 transcription repressor |
Gfi1b
|
ENSMUSG00000026815.8 | growth factor independent 1B |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr5_107725413_107725590 | Gfi1 | 304 | 0.502982 | 0.38 | 4.6e-03 | Click! |
chr5_107723670_107723821 | Gfi1 | 598 | 0.561842 | 0.21 | 1.2e-01 | Click! |
chr5_107719877_107720028 | Gfi1 | 4391 | 0.132504 | 0.16 | 2.3e-01 | Click! |
chr5_107717890_107718041 | Gfi1 | 6378 | 0.120409 | 0.07 | 5.9e-01 | Click! |
chr5_107725780_107725931 | Gfi1 | 50 | 0.892042 | 0.07 | 6.1e-01 | Click! |
chr2_28616890_28617255 | Gfi1b | 1667 | 0.233190 | -0.93 | 3.8e-24 | Click! |
chr2_28621832_28622196 | Gfi1b | 32 | 0.958340 | -0.92 | 7.6e-24 | Click! |
chr2_28617336_28617532 | Gfi1b | 2029 | 0.196198 | -0.91 | 1.7e-21 | Click! |
chr2_28617572_28617880 | Gfi1b | 2321 | 0.176680 | -0.90 | 6.0e-21 | Click! |
chr2_28621011_28621181 | Gfi1b | 849 | 0.456685 | -0.89 | 5.6e-20 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_71925272_71925574 | 72.15 |
Polr1a |
polymerase (RNA) I polypeptide A |
671 |
0.56 |
chr7_73399870_73400476 | 63.46 |
Gm44758 |
predicted gene 44758 |
4177 |
0.15 |
chr7_61939801_61940302 | 61.40 |
Mir344-2 |
microRNA 344-2 |
55 |
0.95 |
chr10_37378360_37378791 | 57.44 |
Gm26535 |
predicted gene, 26535 |
41089 |
0.18 |
chr13_83721535_83721983 | 53.04 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
378 |
0.8 |
chr4_9269199_9269403 | 49.37 |
Clvs1 |
clavesin 1 |
8 |
0.98 |
chr2_59562684_59563070 | 48.50 |
Gm13552 |
predicted gene 13552 |
1807 |
0.42 |
chr13_105250811_105251272 | 47.38 |
Rnf180 |
ring finger protein 180 |
19998 |
0.22 |
chr12_68996810_68996961 | 45.39 |
Gm47515 |
predicted gene, 47515 |
1915 |
0.32 |
chr4_71840383_71840625 | 43.44 |
Gm11233 |
predicted gene 11233 |
27484 |
0.23 |
chr12_12680715_12680959 | 42.38 |
Gm27952 |
predicted gene, 27952 |
1781 |
0.32 |
chr13_84065521_84065798 | 42.23 |
Gm17750 |
predicted gene, 17750 |
887 |
0.64 |
chr18_50034876_50035293 | 42.17 |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
4055 |
0.24 |
chr15_32034795_32035210 | 41.61 |
Gm49285 |
predicted gene, 49285 |
14949 |
0.27 |
chr13_84060041_84060314 | 40.41 |
Gm17750 |
predicted gene, 17750 |
4595 |
0.25 |
chr1_71342333_71342484 | 39.85 |
Abca12 |
ATP-binding cassette, sub-family A (ABC1), member 12 |
6622 |
0.3 |
chr7_4477936_4478899 | 39.76 |
Eps8l1 |
EPS8-like 1 |
751 |
0.41 |
chr13_15759168_15760299 | 39.75 |
Gm48408 |
predicted gene, 48408 |
10387 |
0.18 |
chr14_14347096_14348750 | 39.37 |
Gm48860 |
predicted gene, 48860 |
659 |
0.44 |
chr12_26635257_26635560 | 38.47 |
1700020D12Rik |
RIKEN cDNA 1700020D12 gene |
33099 |
0.18 |
chr2_79459975_79460605 | 37.81 |
Cerkl |
ceramide kinase-like |
3505 |
0.25 |
chr2_142163984_142164173 | 37.17 |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
12529 |
0.32 |
chr1_6733683_6734408 | 37.16 |
St18 |
suppression of tumorigenicity 18 |
825 |
0.73 |
chr3_88206531_88206915 | 35.90 |
Gm3764 |
predicted gene 3764 |
90 |
0.91 |
chrX_143906539_143906984 | 35.50 |
Dcx |
doublecortin |
26289 |
0.21 |
chr19_38054215_38055320 | 35.01 |
I830134H01Rik |
RIKEN cDNA I830134H01 gene |
239 |
0.48 |
chr6_55791826_55792546 | 34.92 |
Itprid1 |
ITPR interacting domain containing 1 |
44709 |
0.18 |
chr6_31948254_31948407 | 34.84 |
1700012A03Rik |
RIKEN cDNA 1700012A03 gene |
101916 |
0.07 |
chr4_25627471_25627842 | 34.71 |
Gm24977 |
predicted gene, 24977 |
60834 |
0.11 |
chr10_87488880_87489066 | 34.60 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
4687 |
0.22 |
chr14_119098858_119099851 | 34.56 |
Uggt2 |
UDP-glucose glycoprotein glucosyltransferase 2 |
76 |
0.84 |
chr10_75559168_75559843 | 34.27 |
Lrrc75b |
leucine rich repeat containing 75B |
825 |
0.43 |
chr19_36534720_36535517 | 33.30 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
19521 |
0.2 |
chr9_41735944_41736314 | 33.01 |
Gm35835 |
predicted gene, 35835 |
1251 |
0.45 |
chr8_55940261_55940432 | 32.44 |
Glra3 |
glycine receptor, alpha 3 subunit |
114 |
0.97 |
chr6_22205459_22205620 | 31.62 |
Gm42573 |
predicted gene 42573 |
40395 |
0.17 |
chr16_26901621_26901772 | 31.58 |
Gmnc |
geminin coiled-coil domain containing |
63910 |
0.14 |
chr1_67558856_67559007 | 31.56 |
Kif22-ps |
kinesin family member 22, pseudogene |
26122 |
0.23 |
chr8_25392912_25393353 | 31.40 |
Gm39147 |
predicted gene, 39147 |
5888 |
0.16 |
chr2_142334534_142334733 | 31.24 |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
158026 |
0.04 |
chr1_89400509_89401229 | 31.19 |
C030007H22Rik |
RIKEN cDNA C030007H22 gene |
5264 |
0.23 |
chr4_72384628_72385513 | 31.12 |
Gm11235 |
predicted gene 11235 |
157596 |
0.04 |
chr2_179481364_179481534 | 31.11 |
Cdh4 |
cadherin 4 |
37216 |
0.18 |
chr10_41934443_41935500 | 31.09 |
Sesn1 |
sestrin 1 |
36598 |
0.15 |
chr16_46009777_46011157 | 30.54 |
Plcxd2 |
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
249 |
0.91 |
chr6_91839077_91839294 | 30.51 |
Grip2 |
glutamate receptor interacting protein 2 |
11935 |
0.16 |
chr17_48999548_48999943 | 30.14 |
Lrfn2 |
leucine rich repeat and fibronectin type III domain containing 2 |
67366 |
0.11 |
chr18_12026401_12026631 | 29.56 |
Tmem241 |
transmembrane protein 241 |
48115 |
0.14 |
chr19_21494190_21494506 | 29.50 |
Gda |
guanine deaminase |
20903 |
0.22 |
chr5_71248443_71248808 | 29.42 |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2 |
152776 |
0.04 |
chr1_79581109_79581473 | 29.32 |
Gm37886 |
predicted gene, 37886 |
39743 |
0.15 |
chr2_64394982_64395325 | 29.21 |
Gm13575 |
predicted gene 13575 |
1293 |
0.6 |
chr6_10969635_10970167 | 29.20 |
AA545190 |
EST AA545190 |
4477 |
0.3 |
chr4_54652062_54652379 | 29.16 |
Gm12480 |
predicted gene 12480 |
317 |
0.87 |
chr14_35112651_35112809 | 28.99 |
Gm49034 |
predicted gene, 49034 |
106708 |
0.07 |
chr12_28860065_28860473 | 28.81 |
Eipr1 |
EARP complex and GARP complex interacting protein 1 |
2580 |
0.25 |
chr13_84783651_84783837 | 28.81 |
Gm26913 |
predicted gene, 26913 |
92803 |
0.09 |
chr16_63091747_63091940 | 28.70 |
Gm49621 |
predicted gene, 49621 |
19847 |
0.25 |
chr6_111449035_111449353 | 28.50 |
Grm7 |
glutamate receptor, metabotropic 7 |
46521 |
0.2 |
chr2_123813197_123813966 | 28.47 |
Sema6d |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
276388 |
0.02 |
chr1_42703489_42704501 | 28.40 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4057 |
0.16 |
chr9_50832696_50833456 | 28.32 |
Alg9 |
asparagine-linked glycosylation 9 (alpha 1,2 mannosyltransferase) |
2495 |
0.22 |
chr17_56502506_56502807 | 28.28 |
Znrf4 |
zinc and ring finger 4 |
9775 |
0.14 |
chr12_45671592_45671761 | 28.19 |
Gm48518 |
predicted gene, 48518 |
117 |
0.98 |
chr1_139209945_139210131 | 27.94 |
Crb1 |
crumbs family member 1, photoreceptor morphogenesis associated |
7752 |
0.21 |
chr6_37642704_37643180 | 27.90 |
Ybx1-ps2 |
Y box protein 1, pseudogene 2 |
44253 |
0.17 |
chr2_82247007_82247160 | 27.84 |
Zfp804a |
zinc finger protein 804A |
11910 |
0.29 |
chr10_81383963_81384933 | 27.80 |
Dohh |
deoxyhypusine hydroxylase/monooxygenase |
11 |
0.48 |
chr12_47163286_47163464 | 27.70 |
Gm36971 |
predicted gene, 36971 |
1667 |
0.48 |
chr6_107462424_107462843 | 27.57 |
Gm27690 |
predicted gene, 27690 |
13689 |
0.22 |
chr15_60822029_60822653 | 27.31 |
9930014A18Rik |
RIKEN cDNA 9930014A18 gene |
70 |
0.97 |
chr17_3610948_3611099 | 27.22 |
1700102H20Rik |
RIKEN cDNA 1700102H20 gene |
53154 |
0.12 |
chr7_64742016_64742211 | 26.99 |
Apba2 |
amyloid beta (A4) precursor protein-binding, family A, member 2 |
1726 |
0.43 |
chr15_94803642_94803805 | 26.97 |
Gm25546 |
predicted gene, 25546 |
122337 |
0.06 |
chr8_92460573_92460724 | 26.95 |
Gm45336 |
predicted gene 45336 |
5119 |
0.28 |
chr17_84749345_84749507 | 26.91 |
Lrpprc |
leucine-rich PPR-motif containing |
1836 |
0.32 |
chr5_47557232_47557404 | 26.78 |
Gm17824 |
predicted gene, 17824 |
77184 |
0.12 |
chr19_4711097_4711248 | 26.68 |
Sptbn2 |
spectrin beta, non-erythrocytic 2 |
5 |
0.96 |
chr8_73142666_73143044 | 26.46 |
Gm22532 |
predicted gene, 22532 |
32403 |
0.19 |
chr3_130962179_130962620 | 26.32 |
2010110G14Rik |
RIKEN cDNA 2010110G14 gene |
25062 |
0.12 |
chr13_29195041_29195242 | 26.21 |
Gm11364 |
predicted gene 11364 |
41479 |
0.18 |
chr5_133807102_133807253 | 26.10 |
Gm7902 |
predicted gene 7902 |
35342 |
0.21 |
chr2_84885715_84885998 | 25.90 |
Rtn4rl2 |
reticulon 4 receptor-like 2 |
620 |
0.63 |
chr14_76032657_76033188 | 25.88 |
Gtf2f2 |
general transcription factor IIF, polypeptide 2 |
22057 |
0.18 |
chr2_136108765_136108957 | 25.80 |
Gm14218 |
predicted gene 14218 |
28145 |
0.19 |
chr1_119902273_119903173 | 25.79 |
Gm28209 |
predicted gene 28209 |
407 |
0.77 |
chr13_109927923_109928074 | 25.55 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
1154 |
0.6 |
chrX_49273592_49273893 | 25.53 |
Enox2 |
ecto-NOX disulfide-thiol exchanger 2 |
14470 |
0.24 |
chr13_34129793_34130880 | 25.51 |
Tubb2b |
tubulin, beta 2B class IIB |
18 |
0.96 |
chr18_54720198_54720369 | 25.43 |
Gm5821 |
predicted gene 5821 |
45849 |
0.16 |
chr15_51746562_51746810 | 25.34 |
Eif3h |
eukaryotic translation initiation factor 3, subunit H |
43863 |
0.17 |
chr1_88254702_88255947 | 25.34 |
Mroh2a |
maestro heat-like repeat family member 2A |
2434 |
0.15 |
chr4_119932789_119932978 | 25.33 |
Hivep3 |
human immunodeficiency virus type I enhancer binding protein 3 |
99883 |
0.07 |
chr12_48222098_48222420 | 25.28 |
Gm46327 |
predicted gene, 46327 |
174725 |
0.03 |
chr14_123139523_123139735 | 25.10 |
Gm49294 |
predicted gene, 49294 |
25856 |
0.2 |
chrY_90760297_90760986 | 25.06 |
Gm21860 |
predicted gene, 21860 |
5174 |
0.19 |
chr4_59388426_59388775 | 24.97 |
Gm12527 |
predicted gene 12527 |
19734 |
0.18 |
chr3_115856880_115857079 | 24.94 |
Dph5 |
diphthamide biosynthesis 5 |
30858 |
0.11 |
chr2_34107198_34107369 | 24.94 |
C230014O12Rik |
RIKEN cDNA C230014O12 gene |
446 |
0.84 |
chr8_7691726_7691877 | 24.84 |
Gm25169 |
predicted gene, 25169 |
53037 |
0.16 |
chr14_66319706_66319909 | 24.78 |
Gm41183 |
predicted gene, 41183 |
21422 |
0.13 |
chr14_18573251_18573600 | 24.65 |
Ube2e2 |
ubiquitin-conjugating enzyme E2E 2 |
23816 |
0.17 |
chr12_89811635_89812082 | 24.64 |
Nrxn3 |
neurexin III |
550 |
0.87 |
chr14_117655480_117655655 | 24.61 |
Mir6239 |
microRNA 6239 |
298280 |
0.01 |
chr13_63092925_63093294 | 24.60 |
Aopep |
aminopeptidase O |
14413 |
0.16 |
chr3_141936600_141936978 | 24.57 |
Bmpr1b |
bone morphogenetic protein receptor, type 1B |
5266 |
0.33 |
chr10_106975341_106975492 | 24.47 |
Gm19007 |
predicted gene, 19007 |
26119 |
0.2 |
chr5_39856661_39857212 | 24.45 |
Gm7816 |
predicted pseudogene 7816 |
58722 |
0.14 |
chr5_15934028_15934625 | 24.35 |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
365 |
0.74 |
chr5_126335674_126335842 | 24.31 |
Gm23151 |
predicted gene, 23151 |
53896 |
0.16 |
chr3_107101683_107102123 | 24.29 |
Kcna2 |
potassium voltage-gated channel, shaker-related subfamily, member 2 |
336 |
0.85 |
chr3_17805299_17805450 | 24.18 |
Gm23441 |
predicted gene, 23441 |
1627 |
0.36 |
chrX_141725754_141725924 | 24.16 |
Irs4 |
insulin receptor substrate 4 |
576 |
0.59 |
chr16_67001910_67002077 | 23.99 |
Cadm2 |
cell adhesion molecule 2 |
48659 |
0.19 |
chr2_115979778_115979947 | 23.94 |
Meis2 |
Meis homeobox 2 |
62184 |
0.12 |
chr13_80962745_80963559 | 23.90 |
9330111N05Rik |
RIKEN cDNA 9330111N05 gene |
264 |
0.71 |
chr13_24565549_24566352 | 23.83 |
Ripor2 |
RHO family interacting cell polarization regulator 2 |
16239 |
0.18 |
chr12_68683286_68683474 | 23.76 |
n-R5s61 |
nuclear encoded rRNA 5S 61 |
82410 |
0.08 |
chr3_40120560_40120776 | 23.71 |
Gm42785 |
predicted gene 42785 |
297091 |
0.01 |
chr13_75941029_75941212 | 23.67 |
Rhobtb3 |
Rho-related BTB domain containing 3 |
2747 |
0.16 |
chr18_16713612_16713806 | 23.64 |
Gm15485 |
predicted gene 15485 |
15024 |
0.24 |
chr4_24429061_24429567 | 23.55 |
Gm27243 |
predicted gene 27243 |
1576 |
0.43 |
chr16_23520213_23520935 | 23.52 |
Masp1 |
mannan-binding lectin serine peptidase 1 |
22 |
0.59 |
chr7_96834980_96835207 | 23.49 |
Gm44633 |
predicted gene 44633 |
16787 |
0.14 |
chr19_43626276_43626448 | 23.47 |
Gm22646 |
predicted gene, 22646 |
3916 |
0.13 |
chr6_51057202_51057641 | 23.32 |
Gm44402 |
predicted gene, 44402 |
90153 |
0.08 |
chr11_120349471_120350657 | 23.08 |
0610009L18Rik |
RIKEN cDNA 0610009L18 gene |
1386 |
0.18 |
chr7_57474263_57474422 | 23.08 |
Gabra5 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5 |
35029 |
0.17 |
chr15_8659416_8659937 | 23.07 |
Gm37310 |
predicted gene, 37310 |
4603 |
0.23 |
chr18_29267767_29267918 | 23.03 |
Gm34743 |
predicted gene, 34743 |
22495 |
0.28 |
chr2_137229757_137229948 | 23.01 |
Gm28214 |
predicted gene 28214 |
30869 |
0.21 |
chr8_87690460_87690629 | 22.89 |
Zfp423 |
zinc finger protein 423 |
113279 |
0.06 |
chr14_70659174_70659883 | 22.86 |
Npm2 |
nucleophosmin/nucleoplasmin 2 |
284 |
0.85 |
chr7_18950757_18950953 | 22.83 |
Nova2 |
NOVA alternative splicing regulator 2 |
24967 |
0.07 |
chr2_146745869_146746069 | 22.80 |
Gm14111 |
predicted gene 14111 |
9736 |
0.27 |
chr4_91380726_91381596 | 22.78 |
Elavl2 |
ELAV like RNA binding protein 1 |
4665 |
0.22 |
chr10_19396813_19397100 | 22.77 |
Olig3 |
oligodendrocyte transcription factor 3 |
40423 |
0.16 |
chr14_11555265_11555452 | 22.74 |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
1777 |
0.39 |
chr4_4949114_4949277 | 22.70 |
Gm11779 |
predicted gene 11779 |
29679 |
0.25 |
chr5_5663490_5664099 | 22.69 |
Cfap69 |
cilia and flagella associated protein 69 |
249 |
0.91 |
chr8_90302107_90302493 | 22.64 |
Tox3 |
TOX high mobility group box family member 3 |
45826 |
0.2 |
chr4_109156409_109156616 | 22.61 |
Osbpl9 |
oxysterol binding protein-like 9 |
98 |
0.98 |
chr3_11024565_11024725 | 22.60 |
Gm21631 |
predicted gene, 21631 |
15042 |
0.2 |
chr5_9702816_9702967 | 22.59 |
Grm3 |
glutamate receptor, metabotropic 3 |
22279 |
0.21 |
chr4_125534653_125535467 | 22.58 |
Mir692-2 |
microRNA 692-2 |
30311 |
0.17 |
chr2_44341099_44341330 | 22.55 |
Gm22867 |
predicted gene, 22867 |
87721 |
0.1 |
chr14_105572434_105572633 | 22.47 |
9330188P03Rik |
RIKEN cDNA 9330188P03 gene |
16943 |
0.17 |
chr7_92807635_92807786 | 22.46 |
Rab30 |
RAB30, member RAS oncogene family |
12195 |
0.15 |
chr15_8659976_8660428 | 22.41 |
Gm37310 |
predicted gene, 37310 |
5129 |
0.23 |
chr15_8717051_8717280 | 22.40 |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
6401 |
0.26 |
chr7_140081805_140082771 | 22.36 |
Caly |
calcyon neuron-specific vesicular protein |
20 |
0.95 |
chr3_21891883_21892491 | 22.32 |
7530428D23Rik |
RIKEN cDNA 7530428D23 gene |
91414 |
0.08 |
chr14_91464114_91464271 | 22.30 |
Gm48942 |
predicted gene, 48942 |
183647 |
0.03 |
chr4_107717857_107718028 | 22.23 |
1700047F07Rik |
RIKEN cDNA 1700047F07 gene |
10885 |
0.11 |
chr12_15811718_15812067 | 22.01 |
Trib2 |
tribbles pseudokinase 2 |
4893 |
0.17 |
chr7_76560879_76561212 | 22.01 |
2310001K20Rik |
RIKEN cDNA 2310001K20 gene |
50020 |
0.18 |
chr2_166384683_166384858 | 21.98 |
Gm14268 |
predicted gene 14268 |
13387 |
0.22 |
chr15_13173508_13173824 | 21.96 |
Cdh6 |
cadherin 6 |
9 |
0.99 |
chr14_105333569_105333758 | 21.95 |
Ndfip2 |
Nedd4 family interacting protein 2 |
39117 |
0.13 |
chr14_93067654_93068272 | 21.93 |
Gm23509 |
predicted gene, 23509 |
70226 |
0.12 |
chr10_127621269_127622026 | 21.86 |
Lrp1 |
low density lipoprotein receptor-related protein 1 |
499 |
0.63 |
chr7_34596890_34597065 | 21.84 |
Gm44837 |
predicted gene 44837 |
40735 |
0.11 |
chrX_72895479_72896098 | 21.81 |
Cetn2 |
centrin 2 |
21068 |
0.13 |
chr17_66417056_66417319 | 21.80 |
Gm4705 |
predicted gene 4705 |
3203 |
0.22 |
chr5_113041463_113042083 | 21.78 |
Gm22740 |
predicted gene, 22740 |
2371 |
0.2 |
chr11_26481973_26482124 | 21.78 |
Fancl |
Fanconi anemia, complementation group L |
13713 |
0.23 |
chr18_23037418_23037876 | 21.75 |
Nol4 |
nucleolar protein 4 |
1009 |
0.7 |
chr6_127109478_127109980 | 21.73 |
Tigar |
Trp53 induced glycolysis regulatory phosphatase |
172 |
0.91 |
chr2_127559169_127559677 | 21.71 |
Gm14229 |
predicted gene 14229 |
10003 |
0.12 |
chr12_3236518_3237725 | 21.70 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr5_66675271_66675442 | 21.62 |
Uchl1os |
ubiquitin carboxy-terminal hydrolase L1, opposite strand |
677 |
0.42 |
chr6_39242951_39243777 | 21.61 |
Gm43479 |
predicted gene 43479 |
3250 |
0.2 |
chr1_155306567_155306718 | 21.60 |
Xpr1 |
xenotropic and polytropic retrovirus receptor 1 |
3000 |
0.25 |
chr3_73056881_73057482 | 21.58 |
Slitrk3 |
SLIT and NTRK-like family, member 3 |
238 |
0.92 |
chr2_50971005_50971315 | 21.55 |
Gm13498 |
predicted gene 13498 |
61476 |
0.15 |
chr1_171262550_171263097 | 21.55 |
B4galt3 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 3 |
7505 |
0.07 |
chr6_94631259_94631471 | 21.49 |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
24160 |
0.17 |
chr9_41375999_41376652 | 21.43 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
4 |
0.98 |
chr14_55116352_55116664 | 21.39 |
Jph4 |
junctophilin 4 |
72 |
0.94 |
chr3_129970595_129971442 | 21.36 |
Mcub |
mitochondrial calcium uniporter dominant negative beta subunit |
812 |
0.6 |
chr9_91379182_91379441 | 21.35 |
Zic4 |
zinc finger protein of the cerebellum 4 |
669 |
0.54 |
chr11_104232039_104232621 | 21.34 |
Mapt |
microtubule-associated protein tau |
746 |
0.59 |
chr6_113012483_113012899 | 21.33 |
Gm8083 |
predicted gene 8083 |
20569 |
0.09 |
chr10_96955553_96955748 | 21.31 |
Gm33981 |
predicted gene, 33981 |
3221 |
0.31 |
chr12_26680204_26680596 | 21.31 |
1700020D12Rik |
RIKEN cDNA 1700020D12 gene |
78091 |
0.1 |
chr11_33756639_33756946 | 21.25 |
Gm12120 |
predicted gene 12120 |
51242 |
0.13 |
chr1_38410556_38410724 | 21.18 |
Gm16152 |
predicted gene 16152 |
21811 |
0.22 |
chr6_51754494_51754645 | 21.15 |
Gm38811 |
predicted gene, 38811 |
43488 |
0.16 |
chr12_11518419_11518572 | 21.14 |
Gm47808 |
predicted gene, 47808 |
6105 |
0.2 |
chr5_70995664_70996254 | 21.05 |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2 |
17725 |
0.29 |
chr15_13067529_13067680 | 21.02 |
Gm24664 |
predicted gene, 24664 |
86775 |
0.08 |
chr17_91093116_91093291 | 21.01 |
Nrxn1 |
neurexin I |
132 |
0.95 |
chr4_48779326_48779559 | 21.00 |
Gm24573 |
predicted gene, 24573 |
16480 |
0.2 |
chr13_67728688_67729329 | 20.98 |
Zfp65 |
zinc finger protein 65 |
165 |
0.59 |
chr3_130963122_130963520 | 20.98 |
2010110G14Rik |
RIKEN cDNA 2010110G14 gene |
25984 |
0.12 |
chr14_118437467_118437673 | 20.94 |
Gm5672 |
predicted gene 5672 |
61376 |
0.09 |
chr7_51772497_51772673 | 20.94 |
Gm29296 |
predicted gene 29296 |
141 |
0.96 |
chr13_41759205_41759377 | 20.92 |
Adtrp |
androgen dependent TFPI regulating protein |
41275 |
0.13 |
chr4_22490184_22490452 | 20.91 |
Gm30731 |
predicted gene, 30731 |
230 |
0.9 |
chr14_103778974_103779176 | 20.89 |
Ednrb |
endothelin receptor type B |
64620 |
0.12 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
30.1 | 90.4 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
18.9 | 56.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
13.4 | 40.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
10.8 | 32.4 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
10.4 | 31.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
10.3 | 72.2 | GO:0016198 | axon choice point recognition(GO:0016198) |
9.8 | 58.8 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
9.2 | 36.8 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
9.1 | 27.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
9.1 | 18.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
8.9 | 26.7 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
8.8 | 43.8 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
8.7 | 26.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
8.5 | 25.5 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
8.5 | 17.0 | GO:1902688 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
8.4 | 33.6 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
8.3 | 33.2 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
8.2 | 8.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
8.2 | 24.6 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
7.8 | 23.3 | GO:0046684 | response to pyrethroid(GO:0046684) |
7.2 | 21.7 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
7.1 | 21.4 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
6.8 | 20.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
6.7 | 59.9 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
6.6 | 19.8 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
6.5 | 32.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
6.5 | 19.4 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
6.4 | 12.8 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
6.2 | 12.3 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
5.8 | 17.4 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
5.7 | 45.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
5.5 | 16.6 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
5.5 | 16.5 | GO:0021856 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
5.5 | 16.4 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
5.4 | 16.2 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
5.3 | 15.8 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
5.2 | 41.7 | GO:0071420 | cellular response to histamine(GO:0071420) |
5.1 | 15.4 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
5.1 | 5.1 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
5.1 | 15.2 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
5.0 | 10.1 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
5.0 | 14.9 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
4.9 | 9.8 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
4.9 | 24.3 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
4.8 | 9.6 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
4.7 | 18.9 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
4.7 | 14.1 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
4.6 | 9.2 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
4.6 | 18.4 | GO:0007412 | axon target recognition(GO:0007412) |
4.6 | 18.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
4.6 | 13.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
4.5 | 4.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
4.5 | 13.6 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
4.5 | 9.0 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
4.4 | 17.6 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
4.4 | 13.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
4.4 | 34.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
4.3 | 12.9 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
4.3 | 17.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
4.3 | 21.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
4.2 | 12.7 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
4.2 | 12.7 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
4.2 | 4.2 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
4.2 | 12.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
4.2 | 16.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
4.1 | 4.1 | GO:0048382 | mesendoderm development(GO:0048382) |
4.1 | 8.2 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
4.1 | 8.1 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
4.1 | 8.1 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
4.0 | 16.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
4.0 | 28.1 | GO:0021860 | pyramidal neuron development(GO:0021860) |
4.0 | 11.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
4.0 | 15.9 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
4.0 | 7.9 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
4.0 | 15.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
3.9 | 15.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
3.9 | 11.7 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
3.9 | 7.8 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
3.9 | 7.8 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
3.9 | 15.4 | GO:0030035 | microspike assembly(GO:0030035) |
3.8 | 11.5 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
3.8 | 45.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
3.8 | 15.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
3.8 | 11.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
3.6 | 29.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
3.6 | 10.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
3.6 | 7.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
3.6 | 10.7 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
3.5 | 17.5 | GO:0033762 | response to glucagon(GO:0033762) |
3.5 | 24.5 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
3.5 | 17.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
3.4 | 3.4 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
3.4 | 3.4 | GO:0061205 | paramesonephric duct development(GO:0061205) |
3.4 | 13.7 | GO:0061055 | myotome development(GO:0061055) |
3.4 | 20.4 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
3.4 | 33.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
3.4 | 13.5 | GO:0006551 | leucine metabolic process(GO:0006551) |
3.4 | 13.5 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
3.3 | 13.4 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
3.3 | 13.3 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
3.3 | 13.2 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
3.3 | 3.3 | GO:0007403 | glial cell fate determination(GO:0007403) |
3.3 | 13.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
3.3 | 6.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
3.3 | 9.8 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
3.3 | 13.0 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
3.2 | 9.7 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
3.2 | 3.2 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
3.2 | 16.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
3.2 | 6.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
3.2 | 22.4 | GO:0099515 | actin filament-based transport(GO:0099515) |
3.2 | 19.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
3.2 | 31.7 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
3.1 | 59.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
3.1 | 9.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
3.1 | 24.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
3.1 | 12.2 | GO:0035627 | ceramide transport(GO:0035627) |
3.0 | 6.1 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
3.0 | 9.0 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
3.0 | 12.0 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
3.0 | 24.0 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
3.0 | 3.0 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
3.0 | 9.0 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
3.0 | 9.0 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
3.0 | 9.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
3.0 | 17.9 | GO:0071625 | vocalization behavior(GO:0071625) |
3.0 | 3.0 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
3.0 | 17.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
3.0 | 5.9 | GO:0060594 | mammary gland specification(GO:0060594) |
2.9 | 5.9 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
2.9 | 11.8 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
2.9 | 5.8 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
2.9 | 11.7 | GO:0001927 | exocyst assembly(GO:0001927) |
2.9 | 8.7 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
2.9 | 5.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
2.9 | 11.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
2.9 | 14.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
2.8 | 11.4 | GO:0030091 | protein repair(GO:0030091) |
2.8 | 28.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
2.8 | 11.2 | GO:0003139 | secondary heart field specification(GO:0003139) |
2.8 | 5.6 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
2.8 | 22.1 | GO:0060074 | synapse maturation(GO:0060074) |
2.7 | 5.5 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
2.7 | 5.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
2.7 | 32.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
2.7 | 5.4 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
2.7 | 51.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
2.7 | 8.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
2.7 | 213.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
2.7 | 8.0 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
2.7 | 144.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
2.6 | 5.3 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
2.6 | 13.1 | GO:0022605 | oogenesis stage(GO:0022605) |
2.6 | 5.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
2.6 | 26.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
2.6 | 7.7 | GO:0046959 | habituation(GO:0046959) |
2.6 | 7.7 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
2.6 | 5.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
2.5 | 5.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
2.5 | 63.1 | GO:0007416 | synapse assembly(GO:0007416) |
2.5 | 10.0 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
2.5 | 7.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
2.5 | 5.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
2.5 | 12.4 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
2.5 | 9.9 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
2.5 | 4.9 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
2.5 | 7.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
2.4 | 12.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
2.4 | 9.6 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
2.4 | 4.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
2.4 | 7.1 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
2.3 | 7.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
2.3 | 7.0 | GO:0030070 | insulin processing(GO:0030070) |
2.3 | 39.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
2.3 | 6.9 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
2.3 | 4.5 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
2.3 | 18.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
2.3 | 15.8 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
2.2 | 6.7 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
2.2 | 6.7 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
2.2 | 2.2 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
2.2 | 8.9 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
2.2 | 6.7 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
2.2 | 2.2 | GO:0032346 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
2.2 | 6.6 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
2.1 | 8.6 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
2.1 | 4.3 | GO:0021564 | vagus nerve development(GO:0021564) |
2.1 | 2.1 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
2.1 | 29.8 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
2.1 | 4.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
2.1 | 14.8 | GO:0060736 | prostate gland growth(GO:0060736) |
2.1 | 6.3 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
2.1 | 27.0 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
2.0 | 6.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
2.0 | 30.5 | GO:0003417 | growth plate cartilage development(GO:0003417) |
2.0 | 2.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
2.0 | 6.0 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
2.0 | 16.1 | GO:0042428 | serotonin metabolic process(GO:0042428) |
2.0 | 8.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
2.0 | 14.0 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
2.0 | 2.0 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
2.0 | 2.0 | GO:0072240 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
2.0 | 15.6 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
2.0 | 5.9 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.9 | 3.9 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.9 | 3.9 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
1.9 | 5.8 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
1.9 | 3.8 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
1.9 | 1.9 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
1.9 | 7.6 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
1.9 | 1.9 | GO:0003099 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) regulation of the force of heart contraction by chemical signal(GO:0003057) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
1.8 | 5.5 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
1.8 | 1.8 | GO:0090178 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) |
1.8 | 5.5 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
1.8 | 1.8 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.8 | 9.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.8 | 5.4 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
1.8 | 5.4 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.8 | 1.8 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.8 | 21.0 | GO:0001964 | startle response(GO:0001964) |
1.7 | 7.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.7 | 5.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.7 | 5.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
1.7 | 3.5 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
1.7 | 5.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
1.7 | 6.9 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
1.7 | 3.5 | GO:0045760 | positive regulation of action potential(GO:0045760) |
1.7 | 6.9 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.7 | 6.9 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.7 | 1.7 | GO:0060459 | left lung development(GO:0060459) |
1.7 | 8.5 | GO:0097264 | self proteolysis(GO:0097264) |
1.7 | 23.7 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
1.7 | 3.4 | GO:0021826 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
1.7 | 5.1 | GO:0060751 | branch elongation involved in mammary gland duct branching(GO:0060751) |
1.7 | 16.9 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
1.7 | 5.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.7 | 11.8 | GO:0032790 | ribosome disassembly(GO:0032790) |
1.7 | 11.6 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
1.7 | 3.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
1.7 | 6.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.7 | 6.6 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
1.6 | 1.6 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
1.6 | 4.9 | GO:0046098 | guanine metabolic process(GO:0046098) |
1.6 | 11.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
1.6 | 1.6 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
1.6 | 14.3 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
1.6 | 3.2 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
1.6 | 4.7 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.6 | 15.7 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
1.6 | 7.8 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.5 | 9.2 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
1.5 | 10.7 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
1.5 | 12.2 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
1.5 | 3.0 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
1.5 | 3.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
1.5 | 6.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
1.5 | 133.6 | GO:0007612 | learning(GO:0007612) |
1.5 | 1.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
1.5 | 10.4 | GO:0006108 | malate metabolic process(GO:0006108) |
1.5 | 3.0 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
1.5 | 3.0 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
1.5 | 3.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.5 | 3.0 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
1.5 | 10.3 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
1.5 | 1.5 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
1.5 | 4.4 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
1.4 | 4.3 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
1.4 | 4.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.4 | 17.3 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
1.4 | 2.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.4 | 4.3 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
1.4 | 35.6 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
1.4 | 9.9 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
1.4 | 7.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
1.4 | 4.2 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
1.4 | 2.8 | GO:0048664 | neuron fate determination(GO:0048664) |
1.4 | 5.5 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
1.4 | 4.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
1.4 | 2.8 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.4 | 4.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.4 | 4.1 | GO:0097503 | sialylation(GO:0097503) |
1.3 | 5.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.3 | 4.0 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
1.3 | 1.3 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
1.3 | 5.3 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.3 | 2.6 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
1.3 | 2.6 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
1.3 | 1.3 | GO:0021557 | oculomotor nerve development(GO:0021557) |
1.3 | 3.9 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
1.3 | 7.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
1.3 | 3.9 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
1.3 | 2.6 | GO:0035989 | tendon development(GO:0035989) |
1.3 | 3.9 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
1.3 | 5.2 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
1.3 | 5.2 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
1.3 | 16.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
1.3 | 3.8 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.3 | 14.0 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.3 | 2.5 | GO:1902896 | terminal web assembly(GO:1902896) |
1.2 | 3.7 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
1.2 | 6.2 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
1.2 | 8.7 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
1.2 | 5.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
1.2 | 11.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
1.2 | 3.7 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
1.2 | 3.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.2 | 3.6 | GO:0060005 | vestibular reflex(GO:0060005) |
1.2 | 1.2 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.2 | 1.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.2 | 4.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.2 | 4.8 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
1.2 | 4.7 | GO:0051697 | protein delipidation(GO:0051697) |
1.2 | 5.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.2 | 3.5 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.2 | 3.5 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.2 | 7.0 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
1.2 | 7.0 | GO:0022038 | corpus callosum development(GO:0022038) |
1.2 | 3.5 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
1.2 | 6.9 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
1.2 | 22.0 | GO:0009303 | rRNA transcription(GO:0009303) |
1.2 | 32.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
1.2 | 2.3 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
1.1 | 3.4 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.1 | 3.4 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
1.1 | 14.9 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
1.1 | 2.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.1 | 3.4 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.1 | 13.4 | GO:0043248 | proteasome assembly(GO:0043248) |
1.1 | 3.4 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
1.1 | 4.5 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
1.1 | 2.2 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
1.1 | 5.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.1 | 2.2 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.1 | 5.4 | GO:0098868 | bone growth(GO:0098868) |
1.1 | 4.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
1.1 | 1.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
1.1 | 1.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.1 | 4.3 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
1.1 | 3.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
1.1 | 4.3 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
1.1 | 2.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
1.1 | 21.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
1.1 | 3.2 | GO:0038089 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
1.1 | 4.3 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.1 | 3.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.1 | 5.3 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
1.1 | 2.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.1 | 3.2 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
1.1 | 2.1 | GO:0009629 | response to gravity(GO:0009629) |
1.1 | 3.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
1.0 | 3.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.0 | 3.1 | GO:0032513 | regulation of protein phosphatase type 2B activity(GO:0032512) negative regulation of protein phosphatase type 2B activity(GO:0032513) |
1.0 | 4.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
1.0 | 2.1 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
1.0 | 9.3 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
1.0 | 1.0 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
1.0 | 11.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
1.0 | 12.3 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
1.0 | 4.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
1.0 | 7.0 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.0 | 3.0 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
1.0 | 5.0 | GO:0021871 | forebrain regionalization(GO:0021871) |
1.0 | 9.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
1.0 | 4.0 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
1.0 | 4.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
1.0 | 1.0 | GO:0008105 | asymmetric protein localization(GO:0008105) |
1.0 | 1.0 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
1.0 | 2.0 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
1.0 | 3.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.0 | 5.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.0 | 2.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
1.0 | 2.9 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.9 | 1.9 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.9 | 3.8 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.9 | 0.9 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.9 | 0.9 | GO:0090135 | actin filament branching(GO:0090135) |
0.9 | 1.8 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.9 | 0.9 | GO:0021586 | pons maturation(GO:0021586) |
0.9 | 4.6 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.9 | 0.9 | GO:0050957 | equilibrioception(GO:0050957) |
0.9 | 3.6 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.9 | 2.7 | GO:0019230 | proprioception(GO:0019230) |
0.9 | 5.5 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.9 | 7.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.9 | 0.9 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.9 | 0.9 | GO:0060437 | lung growth(GO:0060437) |
0.9 | 19.6 | GO:0019228 | neuronal action potential(GO:0019228) |
0.9 | 0.9 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.9 | 0.9 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.9 | 3.5 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.9 | 8.8 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.9 | 2.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.9 | 0.9 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.9 | 4.3 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.9 | 2.6 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.9 | 2.6 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.9 | 2.6 | GO:0010042 | response to manganese ion(GO:0010042) |
0.9 | 0.9 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.9 | 1.7 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.8 | 5.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.8 | 2.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.8 | 2.5 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.8 | 6.7 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.8 | 0.8 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.8 | 8.4 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.8 | 4.2 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.8 | 1.7 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.8 | 3.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.8 | 0.8 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.8 | 0.8 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.8 | 3.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.8 | 0.8 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.8 | 3.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.8 | 0.8 | GO:0002339 | B cell selection(GO:0002339) |
0.8 | 4.1 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.8 | 5.6 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) |
0.8 | 2.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.8 | 2.4 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.8 | 0.8 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.8 | 4.8 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.8 | 14.3 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.8 | 4.7 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.8 | 3.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.8 | 2.3 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.8 | 3.1 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.8 | 1.6 | GO:0060166 | olfactory pit development(GO:0060166) |
0.8 | 2.3 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.8 | 2.3 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.8 | 3.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.8 | 3.8 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.8 | 1.5 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) negative regulation of ribosome biogenesis(GO:0090071) |
0.8 | 4.5 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.8 | 3.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.7 | 5.2 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.7 | 2.2 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.7 | 3.0 | GO:0009597 | detection of virus(GO:0009597) |
0.7 | 5.2 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.7 | 1.5 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.7 | 3.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.7 | 8.9 | GO:0035412 | regulation of catenin import into nucleus(GO:0035412) |
0.7 | 5.9 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.7 | 1.5 | GO:0072044 | collecting duct development(GO:0072044) |
0.7 | 1.5 | GO:0050955 | thermoception(GO:0050955) |
0.7 | 1.5 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.7 | 0.7 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.7 | 2.2 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.7 | 0.7 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.7 | 1.4 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.7 | 0.7 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.7 | 1.4 | GO:0042637 | catagen(GO:0042637) |
0.7 | 0.7 | GO:0060004 | reflex(GO:0060004) |
0.7 | 2.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.7 | 2.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.7 | 2.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.7 | 5.0 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.7 | 0.7 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.7 | 2.8 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.7 | 4.9 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.7 | 36.8 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.7 | 3.5 | GO:0010934 | macrophage cytokine production(GO:0010934) |
0.7 | 4.2 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.7 | 2.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.7 | 0.7 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.7 | 0.7 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.7 | 2.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.7 | 0.7 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.7 | 1.3 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.7 | 5.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.7 | 3.3 | GO:0060179 | male mating behavior(GO:0060179) |
0.7 | 5.9 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.7 | 2.0 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.7 | 2.6 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.6 | 0.6 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.6 | 1.3 | GO:0051665 | membrane raft localization(GO:0051665) |
0.6 | 2.6 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.6 | 0.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.6 | 1.9 | GO:0019086 | late viral transcription(GO:0019086) |
0.6 | 0.6 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.6 | 3.2 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.6 | 2.6 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.6 | 5.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.6 | 0.6 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.6 | 1.3 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.6 | 0.6 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.6 | 2.5 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.6 | 3.7 | GO:0000012 | single strand break repair(GO:0000012) |
0.6 | 1.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.6 | 1.9 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.6 | 4.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.6 | 3.7 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.6 | 2.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.6 | 4.9 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.6 | 1.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.6 | 0.6 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.6 | 3.6 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.6 | 6.5 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.6 | 1.8 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.6 | 0.6 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.6 | 0.6 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.6 | 1.8 | GO:0071436 | sodium ion export from cell(GO:0036376) sodium ion export(GO:0071436) |
0.6 | 1.2 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.6 | 1.2 | GO:0030432 | peristalsis(GO:0030432) |
0.6 | 1.8 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.6 | 1.2 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.6 | 1.7 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.6 | 1.7 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.6 | 1.7 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.6 | 1.7 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.6 | 1.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.6 | 3.9 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.6 | 1.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.6 | 1.1 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.6 | 1.7 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.6 | 0.6 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.6 | 3.3 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.6 | 1.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.6 | 2.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.6 | 0.6 | GO:0030421 | defecation(GO:0030421) |
0.5 | 1.1 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.5 | 1.6 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.5 | 2.2 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.5 | 0.5 | GO:0021794 | thalamus development(GO:0021794) |
0.5 | 1.6 | GO:0070459 | prolactin secretion(GO:0070459) |
0.5 | 0.5 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.5 | 4.3 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.5 | 2.7 | GO:0015884 | folic acid transport(GO:0015884) |
0.5 | 7.5 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.5 | 0.5 | GO:1902946 | protein localization to early endosome(GO:1902946) |
0.5 | 1.6 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.5 | 4.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.5 | 0.5 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.5 | 1.6 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.5 | 3.6 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.5 | 2.0 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.5 | 4.5 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.5 | 4.0 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.5 | 2.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.5 | 1.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.5 | 2.0 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.5 | 2.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.5 | 0.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.5 | 0.5 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.5 | 2.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.5 | 1.0 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.5 | 1.5 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.5 | 1.0 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.5 | 0.5 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.5 | 1.5 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.5 | 16.5 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.5 | 0.5 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.5 | 3.3 | GO:0014002 | astrocyte development(GO:0014002) |
0.5 | 1.9 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.5 | 0.9 | GO:0001757 | somite specification(GO:0001757) |
0.5 | 0.5 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
0.5 | 0.5 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.5 | 5.6 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.5 | 1.9 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.5 | 0.9 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.5 | 0.5 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.5 | 0.5 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.5 | 1.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.5 | 0.9 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.5 | 0.5 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.5 | 0.9 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.5 | 0.9 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.5 | 4.6 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.5 | 0.5 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.5 | 5.0 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.5 | 1.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 0.9 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.4 | 0.4 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.4 | 0.9 | GO:0071673 | regulation of smooth muscle cell chemotaxis(GO:0071671) positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.4 | 2.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.4 | 1.7 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.4 | 0.9 | GO:0042891 | antibiotic transport(GO:0042891) |
0.4 | 1.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.4 | 9.7 | GO:0007340 | acrosome reaction(GO:0007340) |
0.4 | 0.8 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.4 | 0.8 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.4 | 0.8 | GO:0014028 | notochord formation(GO:0014028) |
0.4 | 3.7 | GO:0036065 | fucosylation(GO:0036065) |
0.4 | 0.8 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.4 | 0.4 | GO:0007494 | midgut development(GO:0007494) |
0.4 | 0.8 | GO:0001839 | neural plate morphogenesis(GO:0001839) |
0.4 | 0.4 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.4 | 0.4 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.4 | 0.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.4 | 1.6 | GO:0031000 | response to caffeine(GO:0031000) |
0.4 | 4.8 | GO:0006415 | translational termination(GO:0006415) |
0.4 | 1.2 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.4 | 1.9 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.4 | 0.4 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.4 | 0.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.4 | 0.8 | GO:0070268 | cornification(GO:0070268) |
0.4 | 1.5 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.4 | 0.8 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.4 | 1.9 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.4 | 6.7 | GO:0097576 | vacuole fusion(GO:0097576) |
0.4 | 2.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.4 | 0.4 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.4 | 0.7 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.4 | 1.1 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.4 | 0.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.4 | 0.4 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.4 | 1.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.4 | 0.4 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.4 | 0.4 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.3 | 1.0 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.3 | 0.3 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.3 | 1.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.3 | 0.7 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.3 | 3.7 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.3 | 0.7 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.3 | 4.7 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.3 | 0.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 0.3 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.3 | 1.3 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.3 | 0.3 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.3 | 0.3 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.3 | 2.3 | GO:0043383 | negative T cell selection(GO:0043383) |
0.3 | 3.9 | GO:0032402 | establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) |
0.3 | 0.3 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.3 | 0.3 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.3 | 1.3 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.3 | 1.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.3 | 0.3 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.3 | 0.9 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 0.3 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.3 | 1.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 0.6 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.3 | 0.9 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.3 | 0.3 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.3 | 2.7 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.3 | 0.9 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.3 | 1.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.3 | 0.3 | GO:0035799 | ureter maturation(GO:0035799) |
0.3 | 1.8 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 0.3 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.3 | 2.6 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.3 | 0.6 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.3 | 0.3 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.3 | 2.3 | GO:0007616 | long-term memory(GO:0007616) |
0.3 | 1.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 2.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.3 | 0.8 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.3 | 1.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 0.3 | GO:0072162 | metanephric mesenchymal cell differentiation(GO:0072162) |
0.3 | 0.6 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.3 | 0.6 | GO:0035088 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.3 | 3.9 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.3 | 1.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.3 | 0.8 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 1.4 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.3 | 1.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.3 | 0.8 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.3 | 0.8 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.3 | 0.3 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.3 | 0.3 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.3 | 0.3 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.3 | 1.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.3 | 0.5 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.3 | 0.5 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.3 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 0.3 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.3 | 0.3 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.3 | 0.5 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.3 | 1.3 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.3 | 0.8 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.3 | 0.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 1.2 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 0.7 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 1.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 1.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.5 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 0.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.5 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.2 | 0.7 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 0.5 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.2 | 5.6 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.2 | 0.5 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.2 | 0.2 | GO:0042747 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.2 | 0.7 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.2 | 0.2 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.2 | 0.2 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.2 | 1.4 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.2 | 0.4 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.2 | 2.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 0.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.2 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.2 | 0.7 | GO:0044838 | cell quiescence(GO:0044838) |
0.2 | 0.2 | GO:0072143 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) |
0.2 | 0.2 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.2 | 0.7 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 0.9 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.2 | 0.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 0.2 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.2 | 1.5 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.2 | 0.8 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.2 | 0.4 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 0.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.2 | 0.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 0.2 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.2 | 0.4 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.2 | 0.2 | GO:0003011 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.2 | 0.2 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.2 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 7.3 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 4.3 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.2 | 0.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.2 | 0.2 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.2 | 2.6 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 0.7 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.2 | 0.4 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.2 | 1.6 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.2 | 0.4 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.2 | 3.6 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.2 | 0.5 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 0.5 | GO:0002254 | kinin cascade(GO:0002254) |
0.2 | 4.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 0.7 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 0.7 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 0.4 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.2 | 0.2 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.2 | 0.2 | GO:0060013 | righting reflex(GO:0060013) |
0.2 | 0.3 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.2 | 0.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 0.7 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.2 | 0.5 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 0.5 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.2 | 0.3 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.2 | 1.0 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.2 | 2.2 | GO:0007588 | excretion(GO:0007588) |
0.2 | 0.2 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.2 | 1.6 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 0.3 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 0.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.3 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.2 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 0.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.1 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.1 | GO:0002371 | dendritic cell cytokine production(GO:0002371) regulation of dendritic cell cytokine production(GO:0002730) |
0.1 | 0.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.3 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 1.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 1.1 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.1 | 0.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 2.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.4 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.1 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 1.3 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.1 | 0.8 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 0.4 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.1 | GO:0070668 | negative regulation of mast cell apoptotic process(GO:0033026) mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 0.2 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 1.2 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.1 | 0.4 | GO:0042160 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 0.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 5.5 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.8 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 1.2 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.5 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.3 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 1.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.2 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.1 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.1 | 0.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.2 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.1 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 2.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.1 | GO:0014048 | regulation of glutamate secretion(GO:0014048) |
0.1 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.3 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 0.3 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.2 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.5 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.4 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.1 | 0.4 | GO:0090382 | phagosome maturation(GO:0090382) |
0.1 | 0.2 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.2 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.3 | GO:0042711 | maternal behavior(GO:0042711) |
0.1 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.9 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.1 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.1 | 0.7 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.3 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.6 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 1.0 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.1 | 0.1 | GO:2001023 | regulation of response to drug(GO:2001023) positive regulation of response to drug(GO:2001025) |
0.1 | 0.2 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.1 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.1 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.3 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.1 | 0.2 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.1 | 0.2 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.0 | 0.0 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.2 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.0 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.0 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.0 | 0.0 | GO:0060746 | parental behavior(GO:0060746) |
0.0 | 1.2 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.7 | GO:0009620 | response to fungus(GO:0009620) |
0.0 | 0.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.0 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.0 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.0 | GO:0072124 | regulation of glomerular mesangial cell proliferation(GO:0072124) |
0.0 | 0.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.0 | 0.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.0 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.0 | 0.0 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.0 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.0 | 0.1 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 0.8 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.0 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.0 | 0.0 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) negative regulation of myeloid dendritic cell activation(GO:0030886) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.4 | 8.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
8.1 | 48.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
6.3 | 31.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
5.9 | 47.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
5.5 | 54.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
5.4 | 21.6 | GO:0045298 | tubulin complex(GO:0045298) |
5.2 | 41.4 | GO:0043083 | synaptic cleft(GO:0043083) |
5.1 | 35.8 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
5.1 | 5.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
5.1 | 15.3 | GO:0097441 | basilar dendrite(GO:0097441) |
4.8 | 14.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
4.4 | 13.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
4.3 | 72.7 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
4.2 | 16.8 | GO:0033269 | internode region of axon(GO:0033269) |
4.1 | 12.2 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
4.0 | 188.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
3.9 | 11.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
3.8 | 42.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
3.8 | 11.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
3.7 | 22.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
3.7 | 62.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
3.5 | 21.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
3.4 | 20.2 | GO:0016589 | NURF complex(GO:0016589) |
3.1 | 3.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
3.1 | 30.6 | GO:0030673 | axolemma(GO:0030673) |
3.0 | 9.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
3.0 | 8.9 | GO:0016939 | kinesin II complex(GO:0016939) |
2.9 | 17.4 | GO:0032584 | growth cone membrane(GO:0032584) |
2.9 | 23.0 | GO:0071437 | invadopodium(GO:0071437) |
2.9 | 8.6 | GO:0072534 | perineuronal net(GO:0072534) |
2.9 | 11.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
2.8 | 11.1 | GO:0044308 | axonal spine(GO:0044308) |
2.7 | 5.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
2.7 | 11.0 | GO:0033010 | paranodal junction(GO:0033010) |
2.7 | 27.1 | GO:0031527 | filopodium membrane(GO:0031527) |
2.6 | 33.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
2.5 | 30.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
2.5 | 2.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
2.5 | 30.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
2.4 | 4.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
2.3 | 52.7 | GO:0044295 | axonal growth cone(GO:0044295) |
2.3 | 15.9 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
2.1 | 2.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
2.1 | 17.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
2.1 | 57.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
2.1 | 45.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
2.0 | 2.0 | GO:0044393 | microspike(GO:0044393) |
2.0 | 29.6 | GO:0005614 | interstitial matrix(GO:0005614) |
2.0 | 5.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
2.0 | 7.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
2.0 | 7.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.9 | 15.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
1.9 | 18.7 | GO:0005687 | U4 snRNP(GO:0005687) |
1.8 | 1.8 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
1.8 | 16.4 | GO:0043194 | axon initial segment(GO:0043194) |
1.8 | 3.5 | GO:0033263 | CORVET complex(GO:0033263) |
1.7 | 15.4 | GO:0032433 | filopodium tip(GO:0032433) |
1.7 | 49.9 | GO:0031941 | filamentous actin(GO:0031941) |
1.6 | 3.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.6 | 6.2 | GO:1990696 | USH2 complex(GO:1990696) |
1.6 | 26.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.5 | 27.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
1.5 | 7.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
1.5 | 4.6 | GO:0016342 | catenin complex(GO:0016342) |
1.5 | 211.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.4 | 16.9 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.4 | 12.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.4 | 9.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.4 | 4.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.3 | 4.0 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
1.3 | 15.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
1.3 | 44.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.3 | 7.6 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
1.3 | 3.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.3 | 2.5 | GO:0005606 | laminin-1 complex(GO:0005606) |
1.2 | 20.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
1.2 | 17.7 | GO:0043205 | fibril(GO:0043205) |
1.2 | 12.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.2 | 4.6 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.1 | 3.4 | GO:0030478 | actin cap(GO:0030478) |
1.1 | 59.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.1 | 10.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.1 | 7.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.1 | 26.8 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
1.1 | 4.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.1 | 10.7 | GO:0031045 | dense core granule(GO:0031045) |
1.1 | 8.5 | GO:0001520 | outer dense fiber(GO:0001520) |
1.1 | 7.4 | GO:0097449 | astrocyte projection(GO:0097449) |
1.0 | 2.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
1.0 | 3.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.0 | 2.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.0 | 2.9 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.0 | 3.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.9 | 3.8 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.9 | 6.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.9 | 6.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.9 | 2.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.8 | 33.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.8 | 50.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.8 | 4.0 | GO:0005579 | membrane attack complex(GO:0005579) |
0.8 | 3.9 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.8 | 3.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.8 | 6.2 | GO:0060091 | kinocilium(GO:0060091) |
0.8 | 3.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.7 | 2.2 | GO:0032280 | symmetric synapse(GO:0032280) |
0.7 | 6.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.7 | 6.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.7 | 68.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.7 | 6.9 | GO:0097440 | apical dendrite(GO:0097440) |
0.7 | 3.4 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.7 | 4.0 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.7 | 5.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.7 | 5.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.7 | 2.0 | GO:0048179 | activin receptor complex(GO:0048179) |
0.7 | 5.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.7 | 45.6 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.7 | 39.8 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.6 | 5.6 | GO:0036156 | inner dynein arm(GO:0036156) |
0.6 | 16.0 | GO:0030175 | filopodium(GO:0030175) |
0.6 | 6.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.6 | 1.8 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.6 | 7.7 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.6 | 1.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.6 | 4.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.6 | 0.6 | GO:0000125 | PCAF complex(GO:0000125) |
0.5 | 1.6 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.5 | 2.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.5 | 2.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.5 | 1.5 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.5 | 41.3 | GO:0060076 | excitatory synapse(GO:0060076) |
0.5 | 1.4 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.4 | 2.2 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.4 | 8.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.4 | 2.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 1.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.4 | 6.2 | GO:0030904 | retromer complex(GO:0030904) |
0.4 | 2.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.4 | 1.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.4 | 2.0 | GO:0071547 | piP-body(GO:0071547) |
0.4 | 5.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.4 | 1.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.4 | 3.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 1.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.4 | 3.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.4 | 1.1 | GO:1990393 | 3M complex(GO:1990393) |
0.3 | 1.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 2.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 1.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 1.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 1.9 | GO:0031512 | motile primary cilium(GO:0031512) |
0.3 | 8.2 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.3 | 0.9 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.3 | 0.9 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.3 | 1.8 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 0.9 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 3.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 12.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.3 | 1.4 | GO:0001940 | male pronucleus(GO:0001940) |
0.3 | 1.3 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.3 | 1.0 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 0.5 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.3 | 0.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 1.8 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 2.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 0.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 1.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 3.4 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.6 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 0.2 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 1.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 7.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 0.8 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 1.1 | GO:0001652 | granular component(GO:0001652) |
0.2 | 5.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 0.5 | GO:0030286 | dynein complex(GO:0030286) |
0.2 | 1.4 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 2.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.2 | 2.0 | GO:0044447 | axoneme part(GO:0044447) |
0.2 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 1.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.1 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.5 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 6.6 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.5 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.7 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 4.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 1.2 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.2 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.1 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.1 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 1.9 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.4 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.0 | 0.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.3 | 48.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
14.7 | 73.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
10.7 | 32.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
9.4 | 28.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
9.2 | 36.8 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
9.0 | 62.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
8.4 | 33.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
8.2 | 41.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
7.8 | 31.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
7.0 | 49.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
7.0 | 56.2 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
7.0 | 20.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
6.8 | 20.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
6.7 | 20.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
5.9 | 17.8 | GO:0045503 | dynein light chain binding(GO:0045503) |
5.9 | 23.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
5.6 | 28.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
5.2 | 31.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
5.1 | 35.9 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
4.9 | 9.7 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
4.8 | 14.4 | GO:0070699 | type II activin receptor binding(GO:0070699) |
4.7 | 14.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
4.5 | 13.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
4.2 | 4.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
4.2 | 12.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
4.2 | 70.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
4.1 | 4.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
4.0 | 12.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
3.8 | 18.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
3.7 | 14.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
3.7 | 11.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
3.6 | 18.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
3.5 | 17.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
3.5 | 14.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
3.5 | 7.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
3.5 | 3.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
3.5 | 20.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
3.4 | 10.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
3.4 | 24.0 | GO:0003680 | AT DNA binding(GO:0003680) |
3.4 | 13.5 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
3.1 | 15.7 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
3.1 | 6.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
3.1 | 15.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
3.1 | 12.3 | GO:0038064 | collagen receptor activity(GO:0038064) |
3.1 | 9.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
3.0 | 9.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
3.0 | 29.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
2.9 | 8.7 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
2.9 | 31.9 | GO:0005522 | profilin binding(GO:0005522) |
2.9 | 11.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
2.8 | 34.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
2.8 | 5.7 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
2.8 | 11.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
2.8 | 8.3 | GO:0004946 | bombesin receptor activity(GO:0004946) |
2.7 | 24.1 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
2.6 | 7.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
2.6 | 10.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
2.6 | 33.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
2.5 | 12.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
2.5 | 17.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
2.4 | 7.3 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
2.4 | 19.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
2.4 | 12.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
2.4 | 43.0 | GO:0005112 | Notch binding(GO:0005112) |
2.4 | 7.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
2.3 | 54.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
2.3 | 30.3 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
2.3 | 9.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
2.3 | 20.8 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
2.3 | 4.6 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
2.2 | 9.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
2.2 | 28.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
2.2 | 26.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
2.2 | 41.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
2.1 | 6.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
2.1 | 14.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
2.0 | 8.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
2.0 | 18.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
2.0 | 8.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
2.0 | 18.0 | GO:0048185 | activin binding(GO:0048185) |
2.0 | 11.8 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
1.9 | 13.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
1.9 | 1.9 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
1.9 | 5.8 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.9 | 21.0 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.9 | 9.5 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
1.9 | 5.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.9 | 3.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.9 | 18.9 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
1.9 | 28.1 | GO:0031402 | sodium ion binding(GO:0031402) |
1.9 | 41.2 | GO:0004119 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.8 | 38.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.8 | 5.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.8 | 20.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
1.8 | 9.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.8 | 17.8 | GO:0051378 | serotonin binding(GO:0051378) |
1.8 | 56.5 | GO:0070888 | E-box binding(GO:0070888) |
1.7 | 5.2 | GO:0035939 | microsatellite binding(GO:0035939) |
1.7 | 5.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
1.7 | 30.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.7 | 40.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.7 | 23.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.6 | 3.2 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
1.6 | 59.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
1.6 | 1.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.6 | 9.5 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
1.6 | 3.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.5 | 1.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.5 | 12.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
1.5 | 3.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.5 | 37.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.5 | 12.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.5 | 41.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.5 | 1.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.5 | 4.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.4 | 5.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.4 | 7.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
1.4 | 2.8 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
1.4 | 7.0 | GO:0030274 | LIM domain binding(GO:0030274) |
1.4 | 4.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.4 | 4.2 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
1.4 | 4.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.4 | 27.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.4 | 2.7 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.3 | 5.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.3 | 2.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
1.3 | 3.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.3 | 19.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
1.3 | 2.6 | GO:0097016 | L27 domain binding(GO:0097016) |
1.3 | 15.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
1.3 | 3.9 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
1.3 | 6.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.3 | 1.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
1.3 | 6.3 | GO:0048495 | Roundabout binding(GO:0048495) |
1.3 | 15.2 | GO:0015026 | coreceptor activity(GO:0015026) |
1.3 | 2.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
1.3 | 11.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
1.3 | 3.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
1.2 | 5.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
1.2 | 2.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.2 | 32.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.2 | 4.7 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
1.2 | 12.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.1 | 1.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
1.1 | 4.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.1 | 6.7 | GO:0043495 | protein anchor(GO:0043495) |
1.1 | 6.7 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
1.1 | 4.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
1.1 | 6.7 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
1.1 | 5.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.1 | 1.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.1 | 5.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.1 | 8.6 | GO:0036122 | BMP binding(GO:0036122) |
1.1 | 5.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.1 | 23.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
1.1 | 3.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
1.0 | 3.1 | GO:0070052 | collagen V binding(GO:0070052) |
1.0 | 5.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.0 | 6.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.0 | 4.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.0 | 15.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
1.0 | 13.5 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
1.0 | 4.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.0 | 4.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
1.0 | 8.2 | GO:0030506 | ankyrin binding(GO:0030506) |
1.0 | 1.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
1.0 | 3.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.0 | 3.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.0 | 6.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.0 | 3.9 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.0 | 9.6 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
1.0 | 2.9 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.9 | 2.8 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.9 | 35.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.9 | 7.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.9 | 14.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.9 | 6.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.9 | 8.3 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.9 | 3.7 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.9 | 6.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.9 | 21.6 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.9 | 0.9 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.9 | 4.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.9 | 4.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.9 | 2.7 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.8 | 16.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.8 | 0.8 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.8 | 1.7 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.8 | 9.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.8 | 2.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.8 | 0.8 | GO:0055100 | adiponectin binding(GO:0055100) |
0.8 | 11.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.8 | 3.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.8 | 5.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.8 | 5.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.8 | 2.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.8 | 11.9 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.8 | 3.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.8 | 3.9 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.8 | 2.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.8 | 4.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.7 | 11.9 | GO:0008418 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.7 | 2.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.7 | 1.5 | GO:0038100 | nodal binding(GO:0038100) |
0.7 | 13.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.7 | 2.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.7 | 5.8 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.7 | 10.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.7 | 2.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.7 | 1.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.7 | 2.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.7 | 5.6 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.7 | 13.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.7 | 4.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.7 | 0.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.7 | 7.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.7 | 0.7 | GO:0030594 | neurotransmitter receptor activity(GO:0030594) |
0.7 | 10.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.7 | 6.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.6 | 1.9 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.6 | 2.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.6 | 1.9 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.6 | 1.3 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.6 | 8.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.6 | 5.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.6 | 1.9 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.6 | 0.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.6 | 1.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.6 | 3.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.6 | 0.6 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.6 | 10.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.6 | 5.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.6 | 8.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.6 | 1.7 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.6 | 10.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.6 | 9.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.6 | 6.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.6 | 2.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.6 | 1.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.6 | 3.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.5 | 2.2 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.5 | 12.9 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.5 | 2.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.5 | 15.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.5 | 2.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.5 | 0.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.5 | 1.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.5 | 0.5 | GO:0034903 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.5 | 1.9 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.5 | 1.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.5 | 18.3 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.5 | 0.9 | GO:0031013 | troponin I binding(GO:0031013) |
0.5 | 1.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.5 | 2.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.5 | 1.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.5 | 2.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.5 | 5.0 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.5 | 1.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 1.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.4 | 0.9 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.4 | 1.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.4 | 3.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.4 | 0.9 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.4 | 0.9 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.4 | 2.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.4 | 2.5 | GO:0070403 | NAD+ binding(GO:0070403) |
0.4 | 2.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.4 | 1.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.4 | 5.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.4 | 6.1 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.4 | 1.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.4 | 6.5 | GO:0019239 | deaminase activity(GO:0019239) |
0.4 | 1.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.4 | 1.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.4 | 2.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 1.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.4 | 1.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 3.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.4 | 0.8 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.4 | 2.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.4 | 1.5 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.4 | 3.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.4 | 1.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.4 | 80.3 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.4 | 1.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.4 | 2.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.4 | 2.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 1.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.4 | 10.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.3 | 1.7 | GO:0035671 | enone reductase activity(GO:0035671) |
0.3 | 2.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 1.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.3 | 1.0 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.3 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 1.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 1.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.3 | 1.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 3.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 2.0 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 0.3 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.3 | 1.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.3 | 3.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.3 | 0.3 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.3 | 2.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 1.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 0.6 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.3 | 1.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.3 | 1.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 1.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 1.2 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.3 | 5.0 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 3.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 2.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.3 | 0.9 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 9.7 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.3 | 0.6 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.3 | 1.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.3 | 0.3 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.3 | 0.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.3 | 12.4 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.3 | 1.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.3 | 1.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.3 | 3.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.3 | 1.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 15.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 0.8 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.3 | 0.8 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 1.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.3 | 0.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 0.3 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.2 | 1.2 | GO:0052759 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.2 | 2.4 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.2 | 3.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 6.0 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.2 | 6.9 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.2 | 5.8 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.2 | 3.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.2 | 4.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 0.2 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.2 | 1.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 10.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 1.0 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 0.4 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 0.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.2 | 5.1 | GO:0005262 | calcium channel activity(GO:0005262) |
0.2 | 0.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 1.8 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 0.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 1.6 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 3.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 1.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.9 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.2 | 6.1 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 1.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 71.2 | GO:0005509 | calcium ion binding(GO:0005509) |
0.2 | 1.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 12.1 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 1.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 2.0 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 9.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 3.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 1.4 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 0.3 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 0.3 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 3.9 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.9 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 1.3 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.1 | 0.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 6.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.3 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.2 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 1.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.1 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 5.4 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.0 | 0.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.7 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 11.9 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 2.7 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 13.5 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.6 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.1 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 0.4 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.0 | 0.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 29.4 | PID ALK2 PATHWAY | ALK2 signaling events |
2.6 | 36.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
2.1 | 43.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.6 | 49.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
1.5 | 15.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.5 | 16.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.5 | 47.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
1.5 | 42.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.5 | 16.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
1.4 | 27.0 | PID REELIN PATHWAY | Reelin signaling pathway |
1.4 | 17.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.2 | 2.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.2 | 13.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.1 | 48.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
1.1 | 14.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
1.0 | 16.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.9 | 1.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.9 | 10.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.9 | 12.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.9 | 2.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.9 | 3.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.9 | 4.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.8 | 24.4 | PID BMP PATHWAY | BMP receptor signaling |
0.8 | 1.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.8 | 133.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.8 | 9.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.7 | 10.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.7 | 2.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.7 | 10.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.7 | 4.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.6 | 3.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.6 | 1.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.6 | 9.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.5 | 3.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.5 | 2.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.5 | 1.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.5 | 17.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.5 | 10.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.4 | 11.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.4 | 13.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.4 | 5.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.4 | 8.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.4 | 16.7 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.4 | 9.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.4 | 0.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 2.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.4 | 0.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 13.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.3 | 3.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 0.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 20.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.3 | 3.0 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 10.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 3.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.3 | 3.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 32.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 0.7 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 1.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 1.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 0.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 1.0 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 5.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.0 | 83.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
5.6 | 129.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
5.4 | 59.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
4.9 | 39.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
4.1 | 57.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
3.8 | 52.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
3.6 | 3.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
3.5 | 76.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
3.3 | 9.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
2.7 | 43.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
2.6 | 39.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
2.6 | 49.9 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
2.5 | 2.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
2.5 | 2.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
2.2 | 15.1 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
2.1 | 39.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
2.0 | 22.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
1.9 | 48.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
1.9 | 26.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.9 | 5.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.9 | 9.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.9 | 9.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
1.9 | 35.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
1.8 | 77.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.7 | 32.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.7 | 3.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
1.6 | 1.6 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
1.6 | 16.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
1.6 | 1.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.5 | 26.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
1.5 | 16.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.5 | 16.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.5 | 54.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.4 | 24.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.4 | 5.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.4 | 9.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.4 | 1.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
1.3 | 10.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
1.3 | 3.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
1.3 | 2.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.3 | 15.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
1.2 | 11.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.2 | 1.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.2 | 1.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
1.2 | 43.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
1.2 | 20.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.2 | 23.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.1 | 4.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.1 | 14.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.1 | 27.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.0 | 8.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
1.0 | 11.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.9 | 0.9 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.9 | 11.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.8 | 8.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.6 | 7.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.6 | 2.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.5 | 8.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.5 | 6.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.5 | 9.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.5 | 5.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.5 | 9.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.5 | 1.9 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.5 | 3.7 | REACTOME OPSINS | Genes involved in Opsins |
0.5 | 6.9 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.4 | 6.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.4 | 5.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 5.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.4 | 1.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.4 | 0.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.4 | 0.8 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.4 | 17.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.4 | 1.4 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.4 | 7.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 0.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 3.0 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.3 | 8.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 4.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 1.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 0.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.3 | 0.6 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 1.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 9.2 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.3 | 0.3 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.3 | 1.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.3 | 2.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.3 | 0.3 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.2 | 1.6 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 5.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 2.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 8.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 2.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 2.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 1.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 1.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 0.8 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.2 | 16.5 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.2 | 2.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 1.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 3.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 3.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.7 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 0.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.0 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.0 | 0.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |